Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000114571 | SCV000489275 | likely benign | Familial cancer of breast | 2016-09-13 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573602 | SCV000666920 | likely benign | Hereditary cancer-predisposing syndrome | 2016-07-09 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001697043 | SCV000727813 | likely benign | not provided | 2021-01-12 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 28779002, 21285249) |
Labcorp Genetics |
RCV000114571 | SCV001618984 | likely benign | Familial cancer of breast | 2023-12-27 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV000114571 | SCV004019675 | benign | Familial cancer of breast | 2023-03-31 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Color Diagnostics, |
RCV000573602 | SCV004357833 | likely benign | Hereditary cancer-predisposing syndrome | 2016-06-22 | criteria provided, single submitter | clinical testing | |
Leiden Open Variation Database | RCV000114571 | SCV001193306 | likely benign | Familial cancer of breast | 2019-05-13 | no assertion criteria provided | curation | Curators: Marc Tischkowitz, Arleen D. Auerbach. Submitter to LOVD: Marc Tischkowitz. |